Optimi Health Corp.

Optimi Health Corp. is a commercial-stage pharmaceutical company focused on the manufacturing and distribution of regulated psychedelic drug products. The company produces finished-dose psilocybin and MDMA capsules, along with active pharmaceutical ingredients, at a Health Canada-licensed, GMP-compliant facility in British Columbia. Its products are supplied to authorized clinical and therapeutic programs, supporting patient access through regulated channels in markets such as Australia and Canada. Optimi Health Corp. serves the growing mental health treatment ecosystem by providing standardized drug products for psychiatrists, clinics, and research programs that require controlled, pharmaceutical-grade supply. The company also develops related product formats within its licensed manufacturing platform, reinforcing its role as a specialized supplier in the pharmaceutical and life sciences sectors.